Alibaba Health Information Technology Limited
SHSC:241 Stock Report
Alibaba Health Information Technology Balance Sheet Health
Financial Health criteria checks 6/6 Alibaba Health Information Technology has a total shareholder equity of CN¥14.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥19.7B and CN¥5.2B respectively. Alibaba Health Information Technology's EBIT is CN¥637.4M making its interest coverage ratio -1.3. It has cash and short-term investments of CN¥9.6B.
Key information Interest coverage ratio -1.3x Cash CN¥9.55b Equity CN¥14.52b Total liabilities CN¥5.19b Total assets CN¥19.71b
Recent financial health updates
Show all updates
Alibaba Health Information Technology Limited to Report First Half, 2025 Results on Nov 13, 2024 Nov 02
Investor sentiment deteriorates as stock falls 24% Oct 09
New minor risk - Share price stability Sep 30
Investor sentiment improves as stock rises 18% Sep 24
Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023) Jul 31
Alibaba Health Information Technology Limited, Annual General Meeting, Aug 30, 2024 Jul 30
Executive Chairman of the Board recently sold HK$559k worth of stock Jun 23
Investor sentiment improves as stock rises 15% Jun 07
New minor risk - Earnings quality May 28
Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023) May 28
Alibaba Health Information Technology Limited to Report Fiscal Year 2024 Results on May 27, 2024 May 16
Investor sentiment improves as stock rises 19% May 02
Investor sentiment deteriorates as stock falls 18% Jan 22
New minor risk - Shareholder dilution Jan 18
First half 2024 earnings released: EPS: CN¥0.033 (vs CN¥0.012 in 1H 2023) Dec 21
First half 2024 earnings released: EPS: CN¥0.033 (vs CN¥0.012 in 1H 2023) Nov 29
Alibaba Health Information Technology Limited Announces Executive Changes Nov 29
Alibaba Health Information Technology Limited to Report First Half, 2024 Results on Nov 28, 2023 Nov 17
Alibaba Health Information Technology Limited Appoints Xu Haipeng as Non-Executive Director Oct 20
Less than half of directors are independent Aug 17
Alibaba Health Information Technology Limited Announces Executive Changes and Committee Changes Aug 12
Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022) Jul 15
Alibaba Health Information Technology Limited, Annual General Meeting, Aug 11, 2023 Jul 14
Chairman of the Board & CEO recently sold HK$587k worth of stock Jun 24
Less than half of directors are independent May 25
Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022) May 24
Alibaba Health Information Technology Limited Announces Board Changes May 17
Alibaba Health Information Technology Limited to Report Fiscal Year 2023 Final Results on May 23, 2023 May 13
Alibaba Health Information Technology Limited Provides Earnings Guidance for the Year Ended March 31, 2023 May 06
First half 2023 earnings released: EPS: CN¥0.012 (vs CN¥0.017 loss in 1H 2022) Nov 30
Alibaba Health Information Technology Limited to Report Q2, 2023 Results on Nov 28, 2022 Nov 17
Less than half of directors are independent Nov 16
Alibaba Health Information Technology Limited Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2022 Oct 27
Now 21% undervalued Jul 29
Now 20% undervalued Jul 13
Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021) Jul 07
Alibaba Health Information Technology Limited, Annual General Meeting, Aug 05, 2022 Jul 06
Alibaba Health Information Technology Limited Announces Executive Changes Jul 01
Now 21% undervalued Jun 14
Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021) May 26
Alibaba Health Information Technology Limited to Report Fiscal Year 2022 Final Results on May 25, 2022 May 14
Less than half of directors are independent Apr 27
Less than half of directors are independent Mar 22
COO & Executive Director recently bought HK$4.5m worth of stock Dec 02
First half 2022 earnings: EPS in line with expectations, revenues disappoint Nov 27
Chairman of the Board & CEO recently bought HK$3.4m worth of stock Aug 07
Full year 2021 earnings released: EPS CN¥0.026 (vs CN¥0.001 loss in FY 2020) Jul 02
CFO & Executive Director recently bought HK$284k worth of stock Jun 16
CFO & Executive Director recently bought HK$284k worth of stock Jun 11
Full year 2021 earnings released: EPS CN¥0.026 (vs CN¥0.001 loss in FY 2020) May 26
CFO & Executive Director recently sold HK$906k worth of stock Mar 23
New 90-day high: HK$28.90 Feb 17
New 90-day high: HK$27.45 Jan 20
New 90-day high: HK$23.20 Dec 04
New 90-day high: HK$23.00 Nov 09
Alibaba Health Information Technology Limited to Report First Half, 2021 Results on Nov 25, 2020 Oct 30
Non-Executive Director recently sold HK$6.9m worth of stock Sep 19
New 90-day low - HK$17.40 Sep 09
Alibaba Health Information Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 10 billion. Aug 13
Financial Position Analysis
Short Term Liabilities: 241's short term assets (CN¥13.5B) exceed its short term liabilities (CN¥5.0B).
Long Term Liabilities: 241's short term assets (CN¥13.5B) exceed its long term liabilities (CN¥162.3M).
Debt to Equity History and Analysis
Debt Level: 241 is debt free.
Reducing Debt: 241 has no debt compared to 5 years ago when its debt to equity ratio was 62.1%.
Debt Coverage: 241 has no debt, therefore it does not need to be covered by operating cash flow .
Interest Coverage: 241 has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}